Move is seen as a way to prevent accidental overdose from opioids by widening who would receive the live-saving medication (Practical Pain Management)
Bibliography: Interventions – Harm Reduction
Injecting Equipment Provision in Scotland 2014/15
This publication reports on details of Injecting Equipment Provision (IEP) to People Who Inject Drugs (PWIDs) across Scotland (An Official Statistics Publication for Scotland)
Report on Supervised Injection Facilities Released
In the midst of growing debate and public interest in supervised injection facilities, Harm Reduction Coalition has released a meeting summary of a consultation on alternatives to public injecting
Youth Risk Behavior Surveillance System
The Youth Risk Behavior Surveillance System (YRBSS) monitors six types of health-risk behaviors that contribute to the leading causes of death and disability among youth and adults (CDC)
Naloxone training in General Practice
As of January 2016, we adopted obligatory Naloxone training as part of our practice policy for all patients being prescribed opiate substitute therapy in the practice (RCGP)
Drug checking brief
This brief provides answers to key questions about drug checking services, like … what are drug-checking services? Why check drugs? What do drug checking services look like around the world? What do they do? How would a service sit within the existing policy context in Australia? What are the legal implications of a service? And what related services and programs are currently operating in Australia? (Unharm)
Alternatives to public injecting
The report provides insights on the potential role of supervised injection facilities in the United States, and considerations for advancing policy, planning and implementation of SIFs based on experiences in other countries (Harm Reduction Coalition)
Service Review: Take Home Naloxone programme in NI
Consultation with service users and service providers (Public Health Agency)
Do no harm – Health, human rights and people who use drugs
Evidence supports the need for a shift in the global approach to drug use. In this report, Do no harm: health, human rights and people who use drugs, UNAIDS shows what works to reduce the impact of HIV and other harms related to drug use (UNAIDS)
The Challenge of Being Young in Modern Britain
Includes substance abuse (YMCA)
Research Report: The New Zealand Drug Harm Index 2016
The New Zealand Drug Harm Index 2016 estimates the social cost of drug-related harms and intervention costs in 2014/15 as NZ$1.8 billion (Ministry of Health, New Zealand)
Effect of policy, economics, and the changing alcohol marketplace on alcohol related deaths in England and Wales
The economic downturn and rises in alcohol taxation seem to have stemmed the persistent rise in alcohol related deaths in England and Wales (BMJ)
Study on Extended-Release Naltrexone in Opioid-Dependent Patients Involved in Criminal Justice System
Investigator-Led Study Showed Treatment With Extended-Release Naltrexone Reduced Relapse Rates and Demonstrated Longer Median Time to Relapse to Opioid Dependence During Six-Month Treatment Period (Bloomberg)
Take Home Naloxone programme in NI
Consultation with service users and service providers (INEF)
What’s in the powder?
Drugs.ie: The ‘What’s in the Powder?’ campaign is the result of a collaboration between three Dublin universities – DIT, TCD, and UCD – and the Ana Liffey Drug Project
Patient motivations, perceptions and experiences of opioid substitution therapy in prison
Our findings have highlighted the challenges facing opioid treatment providers in prison in addressing patient ambivalence towards OST and preferences to cease OST prior to release, and can inform the development of policies and clinical practices that are mindful of patient perspectives and concerns (NDARC)
From Epidemic to Evidence
Effectively Managing The Harms Associated with Crystal Methamphetamine (Drug and Alcohol Research Connections)
Stakeholder perceptions and operational barriers in the training and distribution of take-home naloxone within prisons in England
The distribution of THN within a custodial setting requires consideration of a number of important factors which are discussed (HRJ)
New Report and Monitoring Tool: HIV, HCV, TB and Harm Reduction in Prisons
Even though prisoners do not forfeit their human rights, such as the right to health, there is an enormous gap between health and human rights standards and their effective implementation in places of detention (IHR)
Road to Success: Towards Sustainable Harm Reduction Financing
This report provides guidance, driven by findings from the community of people who inject drugs and their allies, for countries and international partners alike to make this transition (EHRN)
PHILTRE Annual Report 2014-15
WEDINOS provides a mechanism for the anonymous submission and testing of samples of new psychoactive substances and the dissemination of pragmatic harm reduction advice (NHS Wales)
The Association of Directors of Public Health: Position Statement – Take home naloxone
This position statement:
1. provides Directors of Public Health with the ADPH position statement on Naloxone use
2. provides a briefing on take home naloxone schemes and issues for Directors of Public Health to
consider, and
3. provides references and sources for key resources and information
Realising Rights: Developing Human Rights-based Indicators for Drug Control
Briefing for Member States at the International Centre for Science in Drug Policy and UN University event ‘Identifying Common Ground for UNGASS 2016: Rethinking Metrics to Evaluate Drug Policy’ (Harm Reduction International)
Prisoner mental health
There has been significant movement in policy and practice surrounding the approach to managing mental health needs of prisoners over the last two decades, and some improvement has undoubtedly been made. However, there is still a long way to go, and we hope that the lessons identified in this report can help prisons to re-evaluate and improve their practices where appropriate, amid the complex landscape of mental health provision (Prisons and Probation Ombudsman)
New EMCDDA insights into naloxone, the overdose antidote that can help save lives
This issue is explored today in a new report from the EU drugs agency (EMCDDA) entitled Preventing opioid overdose deaths with take-home naloxone
Drug health harms – national intelligence
Notes reflecting presentations and discussion from the ninth meeting of the National Intelligence Network on the health harms associated with drug use, held in London on 2 December 2015 (PHE)
Emergency department-based brief interventions for individuals with substance-related problems: a review of effectiveness
This paper considers five systematic reviews and 16 randomised controlled trials and points to the potential benefits of brief interventions, albeit with a need for more research (EMCDDA
Patient motivations, perceptions and experiences of opioid substitution therapy in prison
This qualitative study aimed to examine patient motivations for, and perceptions and experiences of, OST in prisons in New South Wales, Australia (NDARC)
Mortality and morbidity risks from alcohol consumption in the UK
Analyses using the Sheffield Alcohol Policy Model (v.2.7) to inform the UK Chief Medical Officers’ review of the UK lower risk drinking guidelines (University of Sheffield)
US syringe funding ban impedes HIV and hepatitis C prevention
A federal budget bill now under consideration could lift the funding ban on syringe exchange programmes (Aidsmap)
Mortality in the Melbourne injecting drug user cohort study
Contact with emergency services, particularly for drug overdose, remains a lost opportunity to provide referrals for harm reduction and naloxone training programmes to PWID at greater risk of mortality (Harm Reduction Journal)
Drug-related deaths and deaths among drug users in Ireland
2013 figures from the National Drug-Related Deaths Index (HRB)
Late diagnosis of HIV in the United Kingdom: An evidence review
This report examines the causes of continuing late HIV diagnosis in the United Kingdom and review interventions to reduce the number of individuals presenting late (CPH)
Needle exchange services in Knowsley
An investigation into the needs and experiences of staff and service users (CPH)
The extent and nature of addiction to medicines in Cheshire and Merseyside
The aim of this study was, therefore, twofold: (1) to investigate health professionals’ experiences of ATM and (2) their understanding of optimally identifying and addressing ATM (CPH)
Drug health harms – national intelligence
Notes reflecting presentations and discussion from the eighth meeting of the National Intelligence Network on the health harms associated with drug use (PHE)
How can opioid substitution therapy be optimised to maximise recovery outcomes for service users?
The second and concluding report on opioid substitution therapy from the Advisory Council on the Misuse of Drugs (ACMD)
National Naloxone Programme Scotland
Monitoring Report 2014/15 (ISD)
Widening the availability of naloxone
Guidance (Department of Health)
HIV and young people who inject drugs
Technical brief (WHO)
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- Next Page »
